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The implementation of HTA in medicine pricing and reimbursement policies in Indonesia: 
Insights from multiple stakeholders 
 
Abstract 
 
Objectives 
This study aimed to identify the barriers and facilitators to improve the use of health technology 
assessment (HTA) for the selection of medicines listed in the e-Catalogue and the national formulary 
in Indonesia. 
 
Methods 
Semi-structured interviews were conducted to collect qualitative data. Purposive sampling was used 
to recruit the stakeholders consisting of policymakers, a pharmaceutical industry representative, 
healthcare providers, and patients. The data were analyzed using directed content analysis and 
following the COnsolidated criteria for REporting Qualitative studies (COREQ). 
 
Results 
The twenty-five participants interviewed agreed with the use of HTA for supporting the e-Catalogue 
and the national formulary and perceived the advantages of HTA implementation outweighed the 
disadvantages. Barriers mentioned were a lack of capability of local human resources, financial 
incentives, a clear framework and insufficient data. Strategies suggested to overcome the barriers were 
establishing (inter)national networks to build up.111111111 
 
Conclusions 
Several barriers are currently hampering broad implementation of HTA in medicine pricing and 
reimbursement policy in Indonesia. Solutions to these issues appear feasible and important facilitators 
exist. 
 
Link: https://doi.org/10.1371/journal.pone.0225626 
